CASE REPORT
The patient, a 23-year-old woman, with a history of allergy to penicillin and sulphonamides, had had one previous uneventful general anaesthetic. She was anaesthetised for dilatation and curettage of the uterus on January 30, 1981. Following induction with thiopentone and decamethonium, she developed severe hypotension, tachycardia and cyanosis. Over ninety minutes she was successfully resuscitated with Hartmann's solution, hydrocortisone and stable plasma protein solution (SPPS).
Intradermal testing was carried out on February 28, 1981. The results, shown in Table   ' 1, indicated a positive reaction to decamethonium. The patient was given a letter stating that she was allergic to decamethonium and there was no reaction to thiopentone, suxamethonium and gallamine. On July 15, 1981, she was to undergo removal of three wisdom teeth. Premedication was intramuscular pethidine 100 mg and atropine 0.6 mg. Before induction of anaesthesia her systolic blood pressure was 115 mmHg and pulse rate was 80 per minute. After skin infiltration with lignocaine and 1: 100,000 adrenaline, an intravenous drip of Hartmann's solution was established. Ten minutes later after 150 ml was infused, she was given intravenously, at two minute intervals, suxamethonium 2 mg, then thiopentone 12.5 mg and finally gallamine 2 mg.
After two minutes no reaction had been noticed and the patient was given gallamine 30 mg and after 90 seconds induced with thiopentone 350 mg and suxamethonium 100 mg. A 6.5 mm cuffed Rusch naso-tracheal tube was inserted and anaesthesia maintained with nitrous oxide (3 litres/minute), oxygen (one litre per minute) and intermittent positive pressure ventilation. After intubation the systolic pressure was 90 mmHg and her pulse rate was 110 per minute. The electrocardiograph (ECG) showed sinus rhythm. It was then noticed that she had developed minimal periorbital oedema. Gallamine 120 mg was given. Over the next four minutes, no further changes were observed. Then over a period of five minutes, her systolic pressure progressively dropped to 30 mmHg, while the ECG showed S-T depression and a pulse rate of 130 per minute. No other anaphylactic manifestations were observed. She was ventilated with oxygen and given two intravenous doses of 100 micrograms adrenaline, 300 ml of Hartmann's solution and 500 ml of SPPS over 12 minutes. After 7 minutes her systolic pressure was stable at around 100 mmHg but the sinus tachycardia and S-T segment depression persisted. Anaesthesia was then maintained with nitrous oxide and oxygen. Because of her good response to therapy, the operation was performed and completed in nine minutes. During the operation, she developed a generalised cutaneous flush, and the S-T depression disappeared. At the end of the operation it was apparent that the periorbital oedema had worsened and had spread over the whole face. The postoperative course was uneventful.
INVESTIGA nONS 1. Sequential samples of serum and plasma taken at one hour, three hours, 24 hours and one month after the reaction were measured for levels of C3, C4, total haemolytic complement (CH50) CIq binding assay, Clq3 and C3d" and showed no evidence of complement activation. Prausnitz-Kustner 5 testing in a human volunteer with serum taken one month after the second reaction was positive for IgE antibodies to decamethonium and suxamethonium. Intradermal testing one month after the second reaction (August 15, 1981) showed sensitivity to decamethonium and suxamethonium, as shown in Table 1 . Results expressed as wheal sizelflare size in mm.
Four other patients with life-threatening reactions after suxamethonium confirmed
by intradermal testing were also tested with decamethonium. All had positive tests to decamethonium in serial dilutions. Two patients had positive tests to gallamine. This patient has now been given another letter which states that she has had a hypersensitivity reaction to decamethonium and suxamethonium, and that there was no cutaneous reaction to pancuronium, d-tubocurarine, thiopentone, alcuronium or gallamine. DISCUSSION Over the past ten years one of the authors (MMF) has investigated 184 patients with a presumptive diagnosis of an anaphylactic reaction. Of these, 134 had anaphylactic reactions and 21 patients reacted to suxamethonium. Eighty-five of these patients have subsequently had uneventful anaesthesia when the drug incriminated by intradermal testing was avoided. This patient is the first in the series to have a second severe reaction, and the first to react to decamethonium, which has not previously been documented as a cause of an anaphylactic reaction. 6 It appears that patients who react to suxamethonium are at risk from decamethonium and vice versa. Patients who react to suxamethonium may be at risk from gallamine. One patient who had sensitivity to suxamethonium demonstrated by intradermal Anaesthesia and Intensive Care, Vol. X, No. 2, May, 1982 testing had sensitivity to gallamine, decamethonium, fazadinum and suxamethonium demonstrated by leucocyte histamine release. 7 The absence of a positive intradermal test to suxamethonium on the first testing of this patient is surprising and several possibilities may explain this: 
